XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting

NEXT STORY
EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s Sotrovimab For the Early Treatment of COVID-19
PREV STORY
Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx BioPharma Announces Positive Outcome with MS1819-SD Showing Statistically Significant Efficacy in a Phase IIa Exocrine Pancreatic Insufficiency Trial in Chronic Pancreatitis

Data reaffirms positive safety profile with no severe adverse eventsNEW YORK, Sept. 24, 2018 ...

author_avatar
NASDAQ Market News

Idera Pharmaceuticals Presents ILLUMINATE-101 Data Demonstrating Tilsotolimod Activates Innate and Adaptive Immunity as Monotherapy in Patients with Refractory Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting

author_avatar
NASDAQ Market News

Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results  

RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader ...

author_avatar
NASDAQ Market News